Publications by authors named "Eldri Undlien Due"

Claim this Profile
A
An independent poor-prognosis subtype of breast cancer defined by a distinct tumor immune microenvironment.
Xavier Tekpli, Tonje Lien, Andreas Hagen Røssevold, Daniel Nebdal, Elin Borgen, Eldri Undlien Due

Nat Commun· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug-screening and genomic analyses of HER2-positive breast cancer cell lines reveal predictors for treatment response.
Sandra Jernström, Vesa Hongisto, Suvi-Katri Leivonen, Eldri Undlien Due, Dagim Shiferaw Tadele

Breast Cancer (Dove Med Press)· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth.
Suvi-Katri Leivonen, Kristine Kleivi Sahlberg, Rami Mäkelä, Eldri Undlien Due, Olli Kallioniemi

Mol Oncol· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of arrayed primer extension for TP53 mutation detection in breast and ovarian carcinomas.
Pedro Kringen, Anna Bergamaschi, Eldri Undlien Due, Yun Wang, Elda Tagliabue

Biotechniques· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis